Celularity Inc. (CELU) P/E Ratio History
Historical price-to-earnings valuation from 2022 to 2023
Loading P/E history...
CELU Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 9, 2026, Celularity Inc. (CELU) trades at a price-to-earnings ratio of -0.2x, with a stock price of $0.88 and trailing twelve-month earnings per share of $-3.58.
The current P/E is 101% below its 5-year average of 22.0x. Over the past five years, CELU's P/E has ranged from a low of 6.2x to a high of 43.1x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 21.9x, CELU trades at a 101% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 176.0x.
Relative to the broader market, CELU trades at a notable discount to the S&P 500 median P/E of 24.9x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CELU DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CELU Historical P/E Data (2022–2023)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $6.20 | $1.00 | 6.2x | -72% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $12.90 | $0.30 | 43.1x | +96% |
| FY2022 Q2 | $34.00 | $2.06 | 16.5x | -25% |
Average P/E for displayed period: 22.0x
See CELU's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CELU Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CELU vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCELU — Frequently Asked Questions
Quick answers to the most common questions about buying CELU stock.
Is CELU stock overvalued or undervalued?
CELU trades at -0.2x P/E, below its 5-year average of 22.0x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does CELU's valuation compare to peers?
Celularity Inc. P/E of -0.2x compares to sector median of 21.9x. The discount suggests lower growth expectations or higher risk.
What is CELU's PEG ratio?
CELU PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2022-2023.